DavidGaryKrefetzDO

Clinical Trials

• Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression Start of enrollment: 2011 May 01

  Completed

  Phase 2

• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome Start of enrollment: 2011 Mar 01

  Completed

  Phase 3

• Major Depressive Disorder With Mixed Features Start of enrollment: 2012 Jan 01

  Withdrawn

  Phase 3

• Major Depressive Disorder With Mixed Features - Extension Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01

  Completed

  Phase 2

• Bioavailability of LY03004 and Risperdal® Consta® Start of enrollment: 2014 Sep 01

  Completed

  Phase 1

• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01

  Completed

  Phase 2, Phase 3

• Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30

  Completed

  Phase 3

• A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD Start of enrollment: 2015 Dec 22

  Completed

  Phase 1

• A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31

  Completed

  Phase 1

• Join now to see all